Tomoyuki Ijiro Selected Research

Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)

1/2022	Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
9/2020	Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
8/2015	Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoyuki Ijiro Research Topics

Disease

3	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 01/2022 - 08/2015
2	Ataxia (Dyssynergia) 01/2022 - 09/2020
1	Atrophy 01/2022
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2020
1	Parkinson Disease (Parkinson's Disease) 12/2015
1	Fatty Liver 10/2008
1	Alcoholic Fatty Liver 10/2008
1	Fibrosis (Cirrhosis) 10/2008
1	Inflammation (Inflammations) 10/2008

Drug/Important Bio-Agent (IBA)

3	rovatirelinIBA 01/2022 - 08/2015
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 12/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 01/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2008
1	BezafibrateIBA 10/2008
1	Messenger RNA (mRNA)IBA 10/2008
1	CytokinesIBA 10/2008
1	ChemokinesIBA 10/2008

Therapy/Procedure

1	Oral Administration 01/2022